Читать книгу Assisted Reproduction Techniques - Группа авторов - Страница 33

1 1 Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2016. HIV Surveillance Supplemental Report. 2019; 24(No. 1). http://www.cdc.gov/hiv/library/reports/hiv‐surveillance.html. Published February 2019.

2 2 Joint United Nations Programme on HIV/AIDS. Global HIV & AIDS Statistics ‐ 2019 Fact Sheet. 2019. https://www.unaids.org/en/resources/fact‐sheet.

3 3 St Louis ME, Kamenga M, Brown C, Nelson AM, Manzila T, Batter V, et al. Risk for perinatal HIV‐1 transmission according to maternal immunologic, virologic, and placental factors. JAMA. 1993; 69:2853–9.

4 4 International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: a meta‐analysis of 15 prospective cohort studies. N Engl J Med. 1999; 340:977–87.

5 5 Centers for Disease Control and Prevention. HIV and Pregnant Women, Infants, and Children. https://www.cdc.gov/hiv/group/gender/pregnantwomen/index.html Published Match 2019.

6 6 Selph SS, Bougatsos C, Dana T, Grusing S, Chou R. Screening for HIV infection in pregnant women: updated evidence report and systematic review for the US preventive services task force. JAMA. 2019; 321(23):2349–2360.

7 7 Kovacs A, Wasserman SS, Burns D, Wright DJ, Cohn J, Landay A, et al. Determinants of HIV‐1 shedding in the genital tract of women. Lancet. 2001; 358:1593–601.

8 8 Sauer, MV. Providing fertility care to those with HIV: time to re‐examine healthcare policy. Am J Bioethics. 2003; 3:33–40.

9 9 Douglas NC, Wang JG, Yu B, Gaddipati S, Guarnaccia MM, Sauer, MV. A systematic, multidisciplinary approach to address the reproductive needs of HIV‐seropositive women. Reprod BioMed Online. 2009; 19:257–63.

10 10 Ethics Committee of the American Society for Reproductive Medicine. Human immunodeficiency virus (HIV) and infertility treatment: a committee opinion. Fertil Steril. 2015; 104(1):e1–8.

11 11 Vernazza PL, Graf I, Sonnenberg‐Schwan U, Geit M, Meurer A. Preexposure prophylaxis and timed intercourse for HIV‐discordant couples willing to conceive a child. AIDS. 2011; 25:2005–8.

12 12 Sobel JD. Gynecologic infection in human immunodeficiency virus‐infected women. Clin Infect Dis. 2000; 31:1225–33.

13 13 Santulli P, Gayet V, Fauque P, Chopin N, Dulioust E, Wolf JP, et al. HIV‐positive patients undertaking ART have longer infertility histories than age‐matched control subjects. Fertil Steril. 2011; 95(2):507–12.

14 14 Nurudeen SK, Grossman LC, Bourne L, Guarnaccia MM, Sauer MV, Douglas NC. Reproductive outcomes of HIV seropositive women treated by assisted reproduction. J Women’s Health. 2013; 22(3):243–9.

15 15 Savasi V, Mandia L, Laoreti A, Cetin I. Reproductive assistance in HIV serodisordant couples. Human Reproductive Update. 2013; 19:136–150.

16 16 Clark RA, Mulligan K, Stamenovic E, Chang B, Watts H, Andersen J, Squires K, Benson C. Frequency of anovulation and early menopause among women enrolled in selected adult AIDS clinical trials group studies. J Infect Dis. 2001; 184:1325–1327.

17 17 Englert Y, Lesage B, Van Vooren JP, Liesnard C, Place I, Vannin AS, Emiliani S, Delbaere A. Medically assisted reproduction in the presence of chronic viral diseases. Hum Reprod Update. 2004; 10:149–162.

18 18 Seifer DB, Golub ET, Lambert‐Messerlian G, Springer G, Holman S, Moxley M, Cejtin H, Nathwani N, Anastos K, Minkoff H et al. Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women. Fertil Steril. 2007; 88:1645–1652.

19 19 Ohl J, Partisani M, Demangeat C, Binder‐Foucard F, Nisand I, Lang JM. Alterations of ovarian reserve tests in human immunodeficiency virus (HIV)‐infected women. Gynecol Obstet Fertil. 2010; 38:313–317.

20 20 Chirgwin KD, Feldman J, Muneyyirci‐Delale O, Landesman S, Minkoff H. Menstrual function in human immunodeficiency virus‐infected women without acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr Hum Retrovirol. 1996; 12:489–494.

21 21 Cejtin HE, Kalinowski A, Bacchetti P, Taylor RN, Watts DH, Kim S, Massad LS, Preston‐Martin S, Anastos K, Moxley M et al. Effects of human immunodeficiency virus on protracted amenorrhea and ovarian dysfunction. Obstet Gynecol. 2006; 108:1423 –1431.

22 22 Schoenbaum EE, Hartel D, Lo Y, Howard AA, Floris‐Moore M, Arnsten JH, Santoro N. HIV infection, drug use, and onset of natural menopause. Clin Infect Dis. Nov 2005; 41:1517–1524.

23 23 Sedgh G, Larsen U, Spiegelman D, Msamanga G, Fawzi WW. HIV‐1 disease progression and fertility in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 2005; 39:439–45.

24 24 Harlow SD, Schuman P, Cohen M, Ohmit SE, Cu‐Uvin S, Lin X, et al. Effect of HIV infection on menstrual cycle length. J Acquir Immune Defic Syndr. 2000; 24:68–75.

25 25 Seifer DB, Golub ET, Lambert‐Messerlian GL, Springer G, Holman S, Moxley M, et al. Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women. Fertil Steril. 2007; 88:1645–52.

26 26 Ninive C, X Ferraretto, S Gricourt, M A Llabador, J Lepage, C Gauché‐Cazalis, S Epelboin, M Peigné. Assisted reproductive technologies in HIV patients: Which results and which strategy in France in 2019? Gynecologie, Obstetrique, Fertilite & Senologie. 2019; 47(4): 362–369.

27 27 Terriou P, Auquier P, Chabert‐Orsini V, Chinchole JM, Cravello L, Giorgetti C, et al. Outcome of ICSI in HIV‐1‐infected women. Hum Reprod. 2005; 20:2838–43.

28 28 Practice Committee of American Society for Reproductive Medicine. Guidelines for reducing the risk of viral transmission during fertility treatment. Fertil Steril. 2008; 90(Suppl. 5):156–62.

29 29 Sauer, MV. American physicians remain slow to embrace the reproductive needs of human immunodeficiency virus‐infected patients. Fertil Steril. 2006; 85:295–7.

30 30 Ohl J, Partisani M, Wittemer C, Schmitt MP, Cranz C, Stoll‐Keller F, Rongieres C, Bettahar‐Lebugle K, Lang JM, Nisand I. Assisted reproduction techniques for HIV serodiscordant couples: 18 months of experience. Hum Reprod. 2003; 18:1244–1249.

31 31 Coll O, Suy A, Figueras F, Vernaeve V, Martı´nez E, Mataro´ D, Durban M, Lonca M, Vidal R, Gatell JM. Decreased pregnancy rate after in‐vitro fertilization in HIV‐infected women receiving HAART. AIDS. 2006; 20:121–123.

32 32 Marques C, Guerreiro C, Soares SR. Lights and shadows about the effectiveness of IVF in HIV infected women: a systematic review. Infect Dis Obstet Gynecol. 2015; 2015:517208.

33 33 Martinet V, Manigart Y, Rozenberg S, Becker B, Gerard M, Delvigne A. Ovarian response to stimulation of HIV‐positive patients during IVF treatment: a matched, controlled study. Hum Reprod. 2006; 21(5):1212–17.

34 34 Ohl J, Partisani M, Wittemer C, Lang JM, Viville S, Favre R. Encouraging results despite complexity of multidisciplinary care of HIV‐infected women using assisted reproduction techniques. Hum Reprod. 2005; 20:3136–40.